Facebook
Twitter
LinkedIn
ForwardMedication Treatments for Opioid and Alcohol Use Disorders
The purpose of this educational activity is to present the following information to the case management and health coaching staff related to the treatment of substance use disorder. Treatment for substance use disorders involves a combination of behavioral and medical therapeutic options that are tailored to individual needs. The treatment of opioid and alcohol use disorders should involve evaluation of medication options that fit the needs of the patient. Evidence-based medication therapies for OUD and AUD exist and can be managed in a variety of treatment settings including primary care for some. Expanding access to medication treatments for OUD and AUD are key elements in the strategy to reduce morbidity and mortality associated with addiction in our patients.
Time | Content | Presenter |
11-11:15am | Overview of the various medications available to treat opioid use disorder and alcohol use disorder, including dosages and routes of administration | Michael Lynch, MD |
11:15-11:30am | Review of current literature demonstrating evidence of medications' effectiveness | Michael Lynch, MD |
11:30-11:40am | When to use which medication, risks, and benefits; case example | Michael Lynch, MD |
11:40 – 12:00pm | Describe the various initiatives throughout the UPMC system aimed at expanding treatment with medication, including those involving emergency departments and peer support services as examples | Michael Lynch, MD |
Target Audience
RNs / SW / Health Coaches / Dieticians
Learning Objectives
- Describe the different FDA-approved, evidence medication treatments for opioid and alcohol use disorders
- Summarize the evidence of benefit for these medications
- Discuss indications for treatment, potential adverse effects, and medication interactions
- Describe UPMC and UPMC HP initiatives and opportunities to expand access to medication treatment for OUD and AUD
Time | Content | Presenter |
11-11:15am | Overview of the various medications available to treat opioid use disorder and alcohol use disorder, including dosages and routes of administration | Michael Lynch, MD |
11:15-11:30am | Review of current literature demonstrating evidence of medications' effectiveness | Michael Lynch, MD |
11:30-11:40am | When to use which medication, risks, and benefits; case example | Michael Lynch, MD |
11:40 – 12:00pm | Describe the various initiatives throughout the UPMC system aimed at expanding treatment with medication, including those involving emergency departments and peer support services as examples | Michael Lynch, MD |
Michael Lynch, MD Assistant Professor of Emergency Medicine, Toxicology, and Pediatrics; Medical Director of the Pittsburgh Poison Center
Dr. Lynch is a board-certified emergency, toxicology, and addiction medicine physician as well as the medical director of the Pittsburgh Poison Center. He has implemented multiple programs for emergency, outpatient, and inpatient medical management of substance use disorders as well as transitions of care to outpatient primary care and specialty providers.
CCM CE will be provided: 1 CE and sent from UPMC Health Plan nurse planner
As a Jointly Accredited Organization, University of Pittsburgh is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. University of Pittsburgh maintains responsibility for this course. Social workers completing this course receive 1 continuing education credits.
Available Credit
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.00 ASWB
- 1.00 Attendance